Works by Ellingson, Benjamin M

Results: 133
    1

    Single-nucleus expression characterization of non-enhancing region of recurrent high-grade glioma.

    Published in:
    Neuro-Oncology Advances, 2024, v. 6, n. 1, p. 1, doi. 10.1093/noajnl/vdae005
    By:
    • Patel, Kunal S;
    • Tessema, Kaleab K;
    • Kawaguchi, Riki;
    • Dudley, Lindsey;
    • Alvarado, Alvaro G;
    • Muthukrishnan, Sree Deepthi;
    • Perryman, Travis;
    • Hagiwara, Akifumi;
    • Swarup, Vivek;
    • Liau, Linda M;
    • Wang, Anthony C;
    • Yong, William;
    • Geschwind, Daniel H;
    • Nakano, Ichiro;
    • Goldman, Steven A;
    • Everson, Richard G;
    • Ellingson, Benjamin M;
    • Kornblum, Harley I
    Publication type:
    Article
    2

    NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma.

    Published in:
    Neuro-Oncology Advances, 2023, v. 5, n. 1, p. 1, doi. 10.1093/noajnl/vdad124
    By:
    • Sim, Hao-Wen;
    • Wachsmuth, Luke;
    • Barnes, Elizabeth H;
    • Yip, Sonia;
    • Koh, Eng-Siew;
    • Hall, Merryn;
    • Jennens, Ross;
    • Ashley, David M;
    • Verhaak, Roel G;
    • Heimberger, Amy B;
    • Rosenthal, Mark A;
    • Hovey, Elizabeth J;
    • Ellingson, Benjamin M;
    • Tognela, Annette;
    • Gan, Hui K;
    • Wheeler, Helen;
    • Back, Michael;
    • McDonald, Kerrie L;
    • Long, Anne;
    • Cuff, Katharine
    Publication type:
    Article
    3
    4
    5

    Retrospective examination of pseudoprogression in IDH mutant gliomas.

    Published in:
    Neuro-Oncology Advances, 2023, v. 5, n. 1, p. 1, doi. 10.1093/noajnl/vdad028
    By:
    • Wetzel, Ethan A;
    • Farrell, Matthew J;
    • Eldred, Blaine S C;
    • Liu, Vicki;
    • Saha, Ishan;
    • Rinonos, Serendipity Zapanta;
    • Prins, Terry;
    • Li, Tie;
    • Cao, Minsong;
    • Hegde, John;
    • Kaprealian, Tania;
    • Khanlou, Negar;
    • Liau, Linda M;
    • Nghiemphu, Phioanh Leia;
    • Cloughesy, Timothy Francis;
    • Chong, Robert A;
    • Ellingson, Benjamin M;
    • Lai, Albert
    Publication type:
    Article
    6
    7
    8

    TLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in malignant glioma: a randomized phase II Trial.

    Published in:
    Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-48073-y
    By:
    • Everson, Richard G.;
    • Hugo, Willy;
    • Sun, Lu;
    • Antonios, Joseph;
    • Lee, Alexander;
    • Ding, Lizhong;
    • Bu, Melissa;
    • Khattab, Sara;
    • Chavez, Carolina;
    • Billingslea-Yoon, Emma;
    • Salazar, Andres;
    • Ellingson, Benjamin M.;
    • Cloughesy, Timothy F.;
    • Liau, Linda M.;
    • Prins, Robert M.
    Publication type:
    Article
    9
    10
    11
    12
    13

    Novel tonometer device distinguishes brain stiffness in epilepsy surgery.

    Published in:
    Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-77888-0
    By:
    • Fallah, Aria;
    • Subramaniam, Thirusivapragasam;
    • Phillips, H. Westley;
    • Michalet, Xavier;
    • Vinters, Harry V.;
    • Yong, William H.;
    • Wu, Joyce Y.;
    • Salamon, Noriko;
    • Ellingson, Benjamin M.;
    • Wang, Anthony C.;
    • Reyes, Samuel D.;
    • Ibrahim, George M.;
    • Weil, Alexander G.;
    • Chang, Julia W.;
    • Babayan, Diana;
    • Nguyen, Jimmy C.;
    • Behnke, Eric;
    • Tseng, Chi-Hong;
    • Mathern, Gary W.
    Publication type:
    Article
    14
    15
    16
    17
    18

    The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?

    Published in:
    Neuro-Oncology, 2024, v. 26, n. 10, p. 1805, doi. 10.1093/neuonc/noae107
    By:
    • Bent, Martin J van den;
    • French, Pim J;
    • Brat, Daniel;
    • Tonn, Joerg C;
    • Touat, Mehdi;
    • Ellingson, Benjamin M;
    • Young, Robert J;
    • Pallud, Johan;
    • Deimling, Andreas von;
    • Sahm, Felix;
    • Branger, Dominique Figarella;
    • Huang, Raymond Y;
    • Weller, Michael;
    • Mellinghoff, Ingo K;
    • Cloughsey, Tim F;
    • Huse, Jason T;
    • Aldape, Kenneth;
    • Reifenberger, Guido;
    • Youssef, Gilbert;
    • Karschnia, Philipp
    Publication type:
    Article
    19
    20
    21

    Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survival.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 6, p. 1017, doi. 10.1093/neuonc/noad002
    By:
    • Ellingson, Benjamin M;
    • Wen, Patrick Y;
    • Chang, Susan M;
    • van den Bent, Martin;
    • Vogelbaum, Michael A;
    • Li, Gang;
    • Li, Shanpeng;
    • Kim, Jiyoon;
    • Youssef, Gilbert;
    • Wick, Wolfgang;
    • Lassman, Andrew B;
    • Gilbert, Mark R;
    • Groot, John F de;
    • Weller, Michael;
    • Galanis, Evanthia;
    • Cloughesy, Timothy F
    Publication type:
    Article
    22

    Targeting the IL4 receptor with MDNA55 in patients with recurrent glioblastoma: Results of a phase IIb trial.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 6, p. 1085, doi. 10.1093/neuonc/noac285
    By:
    • Sampson, John H;
    • Achrol, Achal Singh;
    • Aghi, Manish K;
    • Bankiewicz, Krystof;
    • Bexon, Martin;
    • Brem, Steven;
    • Brenner, Andrew;
    • Chandhasin, Chandtip;
    • Chowdhary, Sajeel;
    • Coello, Melissa;
    • Ellingson, Benjamin M;
    • Floyd, John R;
    • Han, Seunggu;
    • Kesari, Santosh;
    • Mardor, Yael;
    • Merchant, Fahar;
    • Merchant, Nina;
    • Randazzo, Dina;
    • Vogelbaum, Michael;
    • Vrionis, Frank
    Publication type:
    Article
    23
    24
    25
    26
    27

    Diffusion MRI quality control and functional diffusion map results in ACRIN 6677/RTOG 0625: A multicenter, randomized, phase II trial of bevacizumab and chemotherapy in recurrent glioblastoma.

    Published in:
    International Journal of Oncology, 2015, v. 46, n. 5, p. 1883, doi. 10.3892/ijo.2015.2891
    By:
    • ELLINGSON, BENJAMIN M.;
    • EUNHEE KIM;
    • WOODWORTH, DAVIS C.;
    • MARQUES, HELGA;
    • BOXERMAN, JERROLD L.;
    • SAFRIEL, YAIR;
    • McKINSTRY, ROBERT C.;
    • BOKSTEIN, FELIX;
    • JAIN, RAJAN;
    • CHI, T. LINDA;
    • SORENSEN, A. GREGORY;
    • GILBERT, MARK R.;
    • BARBORIAK, DANIEL P.
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34

    Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumors.

    Published in:
    Neuro-Oncology, 2022, v. 24, n. 8, p. 1219, doi. 10.1093/neuonc/noac086
    By:
    • Ellingson, Benjamin M;
    • Gerstner, Elizabeth R;
    • Lassman, Andrew B;
    • Chung, Caroline;
    • Colman, Howard;
    • Cole, Patricia E;
    • Leung, David;
    • Allen, Joshua E;
    • Ahluwalia, Manmeet S;
    • Boxerman, Jerrold;
    • Brown, Matthew;
    • Goldin, Jonathan;
    • Nduom, Edjah;
    • Hassan, Islam;
    • Gilbert, Mark R;
    • Mellinghoff, Ingo K;
    • Weller, Michael;
    • Chang, Susan;
    • Arons, David;
    • Meehan, Clair
    Publication type:
    Article
    35

    Diffusion MRI is an early biomarker of overall survival benefit in IDH wild-type recurrent glioblastoma treated with immune checkpoint inhibitors.

    Published in:
    Neuro-Oncology, 2022, v. 24, n. 6, p. 1020, doi. 10.1093/neuonc/noab276
    By:
    • Hagiwara, Akifumi;
    • Oughourlian, Talia C;
    • Cho, Nicholas S;
    • Schlossman, Jacob;
    • Wang, Chencai;
    • Yao, Jingwen;
    • Raymond, Catalina;
    • Everson, Richard;
    • Patel, Kunal;
    • Mareninov, Sergey;
    • Rodriguez, Fausto J;
    • Salamon, Noriko;
    • Pope, Whitney B;
    • Nghiemphu, Phioanh L;
    • Liau, Linda M;
    • Prins, Robert M;
    • Cloughesy, Timothy F;
    • Ellingson, Benjamin M
    Publication type:
    Article
    36

    Volumetric measurements are preferred in the evaluation of mutant IDH inhibition in non-enhancing diffuse gliomas: Evidence from a phase I trial of ivosidenib.

    Published in:
    Neuro-Oncology, 2022, v. 24, n. 5, p. 770, doi. 10.1093/neuonc/noab256
    By:
    • Ellingson, Benjamin M;
    • Kim, Grace Hyun J;
    • Brown, Matt;
    • Lee, Jihey;
    • Salamon, Noriko;
    • Steelman, Lori;
    • Hassan, Islam;
    • Pandya, Shuchi S;
    • Chun, Saewon;
    • Linetsky, Michael;
    • Yoo, Bryan;
    • Wen, Patrick Y;
    • Mellinghoff, Ingo K;
    • Goldin, Jonathan;
    • Cloughesy, Timothy F
    Publication type:
    Article
    37

    Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG).

    Published in:
    Neuro-Oncology, 2021, v. 23, n. 7, p. 1056, doi. 10.1093/neuonc/noab020
    By:
    • Barajas, Ramon F;
    • Politi, Letterio S;
    • Anzalone, Nicoletta;
    • Schöder, Heiko;
    • Fox, Christopher P;
    • Boxerman, Jerrold L;
    • Kaufmann, Timothy J;
    • Quarles, C Chad;
    • Ellingson, Benjamin M;
    • Auer, Dorothee;
    • Andronesi, Ovidiu C;
    • Ferreri, Andres J M;
    • Mrugala, Maciej M;
    • Grommes, Christian;
    • Neuwelt, Edward A;
    • Ambady, Prakash;
    • Rubenstein, James L;
    • Illerhaus, Gerald;
    • Nagane, Motoo;
    • Batchelor, Tracy T
    Publication type:
    Article
    38
    39

    Response to Letter to Editor.

    Published in:
    Neuro-Oncology, 2020, v. 22, n. 11, p. 1706, doi. 10.1093/neuonc/noaa202
    By:
    • Kaufmann, Timothy J;
    • Smits, Marion;
    • Boxerman, Jerrold;
    • Huang, Raymond;
    • Barboriak, Daniel P;
    • Weller, Michael;
    • Chung, Caroline;
    • Tsien, Christina;
    • Brown, Paul D;
    • Shankar, Lalitha;
    • Galanis, Evanthia;
    • Gerstner, Elizabeth;
    • Bent, Martin J van den;
    • Burns, Terry C;
    • Parney, Ian F;
    • Dunn, Gavin;
    • Brastianos, Priscilla K;
    • Lin, Nancy U;
    • Wen, Patrick Y;
    • Ellingson, Benjamin M
    Publication type:
    Article
    40

    Volumetric analysis of IDH-mutant lower-grade glioma: a natural history study of tumor growth rates before and after treatment.

    Published in:
    Neuro-Oncology, 2020, v. 22, n. 12, p. 1822, doi. 10.1093/neuonc/noaa105
    By:
    • Huang, Raymond Y;
    • Young, Robert J;
    • Ellingson, Benjamin M;
    • Veeraraghavan, Harini;
    • Wang, Wei;
    • Tixier, Florent;
    • Um, Hyemin;
    • Nawaz, Rasheed;
    • Luks, Tracy;
    • Kim, John;
    • Gerstner, Elizabeth R;
    • Schiff, David;
    • Peters, Katherine B;
    • Mellinghoff, Ingo K;
    • Chang, Susan M;
    • Cloughesy, Timothy F;
    • Wen, Patrick Y
    Publication type:
    Article
    41
    42

    Baseline requirements for novel agents being considered for phase II/III brain cancer efficacy trials: conclusions from the Adult Brain Tumor Consortium's first workshop on CNS drug delivery.

    Published in:
    Neuro-Oncology, 2020, v. 22, n. 10, p. 1422, doi. 10.1093/neuonc/noaa142
    By:
    • Grossman, Stuart A;
    • Romo, Carlos G;
    • Rudek, Michelle A;
    • Supko, Jeffrey;
    • Fisher, Joy;
    • Nabors, L Burt;
    • Wen, Patrick Y;
    • Peereboom, David M;
    • Ellingson, Benjamin M;
    • Elmquist, William;
    • Barker, Fred G;
    • Kamson, David;
    • Sarkaria, Jann N;
    • Timmer, William;
    • Bindra, Ranjit S;
    • Ye, Xiaobu
    Publication type:
    Article
    43

    Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases.

    Published in:
    Neuro-Oncology, 2020, v. 22, n. 6, p. 757, doi. 10.1093/neuonc/noaa030
    By:
    • Kaufmann, Timothy J;
    • Smits, Marion;
    • Boxerman, Jerrold;
    • Huang, Raymond;
    • Barboriak, Daniel P;
    • Weller, Michael;
    • Chung, Caroline;
    • Tsien, Christina;
    • Brown, Paul D;
    • Shankar, Lalitha;
    • Galanis, Evanthia;
    • Gerstner, Elizabeth;
    • Bent, Martin J van den;
    • Burns, Terry C;
    • Parney, Ian F;
    • Dunn, Gavin;
    • Brastianos, Priscilla K;
    • Lin, Nancy U;
    • Wen, Patrick Y;
    • Ellingson, Benjamin M
    Publication type:
    Article
    44

    A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE).

    Published in:
    Neuro-Oncology, 2020, v. 22, n. 5, p. 705, doi. 10.1093/neuonc/noz232
    By:
    • Cloughesy, Timothy F;
    • Brenner, Andrew;
    • Groot, John F de;
    • Butowski, Nicholas A;
    • Zach, Leor;
    • Campian, Jian L;
    • Ellingson, Benjamin M;
    • Freedman, Laurence S;
    • Cohen, Yael C;
    • Lowenton-Spier, Noa;
    • Minei, Tamar Rachmilewitz;
    • Shmueli, Shifra Fain;
    • Investigators, GLOBE Study;
    • Y, Wen Patrick
    Publication type:
    Article
    45

    Safety and efficacy of VB-111, an anticancer gene therapy, in patients with recurrent glioblastoma: results of a phase I/II study.

    Published in:
    Neuro-Oncology, 2020, v. 22, n. 5, p. 694, doi. 10.1093/neuonc/noz231
    By:
    • Brenner, Andrew J;
    • Peters, Katherine B;
    • Vredenburgh, James;
    • Bokstein, Felix;
    • Blumenthal, Deborah T;
    • Yust-Katz, Shlomit;
    • Peretz, Idit;
    • Oberman, Bernice;
    • Freedman, Laurence S;
    • Ellingson, Benjamin M;
    • Cloughesy, Timothy F;
    • Sher, Naamit;
    • Cohen, Yael C;
    • Lowenton-Spier, Noa;
    • Minei, Tamar Rachmilewitz;
    • Yakov, Niva;
    • Mendel, Itzhak;
    • Breitbart, Eyal;
    • Wen, Patrick Y
    Publication type:
    Article
    46
    47
    48
    49
    50